Citation:
Gamble J-M, Chibrikov E, Midodzi WK, Twells LK, Majumdar SR. BMJ open. Examining the risk of depression or self-harm associated with incretin-based therapies used to manage hyperglycaemia in patients with type 2 diabetes: a cohort study using the UK Clinical Practice Research Datalink [Internet]. 2018;Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-85054779701&partnerID=MN8TOARS